Back to search results
NCT05047289

Indiana University Gastric Electrical Stimulation Registry

Enrolling by Invitation
Not specifiedAges 18–80Observational
Indiana University
~1,000 participants
Updated 2026-06-16 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To develop a clinical registry in patients with GES therapy
Measured over 3 years

Conditions

Gastroparesis

Explore related trials

Gastroparesis

Where it's being run

1 sites across 1 states
Indiana1

Study leadership

  • John Wo, MD · PRINCIPAL_INVESTIGATOR · Indiana University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients undergo implantation of a new GES device for medical refractory gastroparesis

Exclusion

Non-ambulatory patients: bed-ridden, nursing home resident, etc.
Pregnancy
Unable to give own informed consent.
Prisoners

What this trial measures

  • To develop a clinical registry in patients with GES therapy3 years

    The purpose of this study is to develop a clinical registry in patients with Gastric Electrical Stimulation (GES) therapy for gastroparesis to support future clinical and translational research. Gastroparesis is an illness caused by a delay of stomach emptying. Symptoms of gastroparesis include nausea, vomiting, weight loss, the feeling of being full right away when you start eating, and abdominal pain. The disease may also lead to malnutrition and weight loss. GES has shown promise in patients with gastroparesis. However, how the GES works is unclear, but the patients who undergo GES show improvement in their symptoms.